Inventor · disambiguated record
David J. Enscore
Also filed as: ENSCORE DAVID · ENSCORE DAVID J · ENSCORE DAVID JAMES
33 granted patents·9 pending applications·3,297 citations·filing 1983–2025
98Inventor score
Top patents by PatentIndex Score
42 records- 0198US6177095B1Polymerizable biodegradable polymers including carbonate or dioxanone linkagesFOCAL INC·Filed 2000·Granted Jan 23, 2001·168 cites·23 claims
- 0297US4559222AMatrix composition for transdermal therapeutic systemALZA CORP·Filed 1983·Granted Dec 17, 1985·238 cites·18 claims
- 0396US5004610ASubsaturated nicotine transdermal therapeutic systemALZA CORP·Filed 1990·Granted Apr 2, 1991·166 cites·29 claims
- 0496US4788062ATransdermal administration of progesterone, estradiol esters, and mixtures thereofALZA CORP·Filed 1987·Granted Nov 29, 1988·231 cites·42 claims
- 0596US4645502ATransdermal delivery of highly ionized fat insoluble drugsALZA CORP·Filed 1985·Granted Feb 24, 1987·189 cites·13 claims
- 0695US5620700AInjectable drug delivery system and methodALZA CORP·Filed 1995·Granted Apr 15, 1997·186 cites·30 claims
- 0795US4908027ASubsaturated transdermal therapeutic system having improved release characteristicsALZA CORP·Filed 1986·Granted Mar 13, 1990·174 cites·29 claims
- 0894US5342623ASubsaturated transdermal therapeutic system having improved release characteristicsALZA CORP·Filed 1993·Granted Aug 30, 1994·144 cites·15 claims
- 0994US4573995ATransdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphineALZA CORP·Filed 1984·Granted Mar 4, 1986·319 cites·33 claims
- 1093US4938759ATransdermal delivery device having a rate controlling adhesiveALZA CORP·Filed 1986·Granted Jul 3, 1990·140 cites·34 claims
- 1193US4904475ATransdermal delivery of drugs from an aqueous reservoirALZA CORP·Filed 1987·Granted Feb 27, 1990·148 cites·19 claims
- 1293US4820720ATransdermal drug composition with dual permeation enhancersALZA CORP·Filed 1988·Granted Apr 11, 1989·159 cites·10 claims
- 1392US6083524APolymerizable biodegradable polymers including carbonate or dioxanone linkagesFOCAL INC·Filed 1997·Granted Jul 4, 2000·226 cites·36 claims
- 1492US5783205AInjectable drug delivery system and methodALZA CORP·Filed 1997·Granted Jul 21, 1998·118 cites·10 claims
- 1589US4832953AMethod for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrixALZA CORP·Filed 1987·Granted May 23, 1989·100 cites·24 claims
- 1688US10166378B2Permeant delivery system and methods for use thereofNITTO DENKO CORP·Filed 2013·Granted Jan 1, 2019·7 cites·49 claims
- 1787US5364630ASubsaturated nicotine transdermal therapeutic systemALZA CORP·Filed 1993·Granted Nov 15, 1994·87 cites·18 claims
- 1886US5462745ASubsaturated transdermal therapeutic system having improved release characteristicsALZA CORP·Filed 1994·Granted Oct 31, 1995·72 cites·10 claims
- 1984US6165497ASubsaturated nicotine transdermal therapeutic systemALZA CORP·Filed 1991·Granted Dec 26, 2000·58 cites·13 claims
- 2084US5633008AMethod of administering nicotine transdermallyFiled 1993·Granted May 27, 1997·66 cites·9 claims
- 2183USRE39713EPolymerizable biodegradable polymers including carbonate or dioxanone linkagesGENZYME CORP·Filed 2003·Granted Jul 3, 2007·33 cites·40 claims
- 2283US6007837ADrug delivery devices and process of manufactureALZA CORP·Filed 1999·Granted Dec 28, 1999·70 cites·16 claims
- 2383US5344656ASubsaturated transdermal therapeutic system having improved release characteristicsALZA CORP·Filed 1993·Granted Sep 6, 1994·62 cites·12 claims
- 2482US9498609B2Permeant delivery system and methods for use thereofTAGLIAFERRI FRANK·Filed 2010·Granted Nov 22, 2016·6 cites·78 claims
- 2581US12318492B2Abuse and misuse deterrent transdermal systemsNUTRIBAND INC·Filed 2023·Granted Jun 3, 2025·0 cites·24 claims
- 2681US4764379ATransdermal drug delivery device with dual permeation enhancersALZA CORP·Filed 1987·Granted Aug 16, 1988·69 cites·25 claims
- 2778US2025288538A1Abuse and misuse deterrent transdermal systemsNUTRIBAND INC·Filed 2025·Application pending·0 cites
- 2874US11759431B2Abuse and misuse deterrent transdermal systemsNUTRIBAND INC·Filed 2022·Granted Sep 19, 2023·0 cites·22 claims
- 2965US11246840B2Abuse and misuse deterrent transdermal systemsNUTRIBAND INC·Filed 2019·Granted Feb 15, 2022·0 cites·27 claims
- 3063US12370149B1Transdermal cannabidiol delivery deviceZHI TECH INC·Filed 2024·Granted Jul 29, 2025·0 cites·26 claims
- 3163US10493254B2Permeant delivery system and methods for use thereofNITTO DENKO CORP·Filed 2017·Granted Dec 3, 2019·0 cites·24 claims
- 3260US2019076374A1Abuse and misuse deterrent transdermal systems4P THERAPEUTICS·Filed 2018·Application pending·0 cites
- 3355US2014294920A1Transdermal propranolol patch for treatment of malignant melanomaNOMETICS INC·Filed 2014·Application pending·0 cites
- 3453US2004220081A1Nanoparticulate bioactive agentsSPHERICS INC·Filed 2003·Application pending·0 cites
- 3549US2017007550A1Abuse and misuse deterrent transdermal systems4P THERAPEUTICS·Filed 2015·Application pending·0 cites
- 3649US2005064027A1Bioadhesive drug delivery system with enhanced gastric retentionSPHERICS INC·Filed 2002·Application pending·0 cites
- 3746US6350463B1Method of treatment for premature rupture of membranes in pregnancy (PROM)ANDRE BIENIARZ·Filed 1999·Granted Feb 26, 2002·52 cites·38 claims
- 3845US6174545B1Drug delivery devices and process of manufactureALZA CORP·Filed 1999·Granted Jan 16, 2001·9 cites·8 claims
- 3942US2003147965A1Methods and products useful in the formation and isolation of microparticlesSPHERICS INC·Filed 2002·Application pending·0 cites
- 4040US11369498B2Stent and stent delivery system with improved deliverabilityMCCLAIN JAMES B·Filed 2011·Granted Jun 28, 2022·0 cites·16 claims
- 4140US2007031495A1Permeant delivery system and methods for use thereofEPPSTEIN JONATHAN·Filed 2006·Application pending·0 cites
- 4237US2005249799A1Polymeric drug delivery system for hydrophobic drugsSPHERICS INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David J. Enscore files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →